Teratogenic drugs in pregnancy

10.5694/j.1326-5377.1983.tb122403.x

Sheffield LJ, 1985, The creation of therapeutic orphans — or, what have we learnt from the Debendox fiasco?, Med J Aust, 143, 143, 10.5694/j.1326-5377.1985.tb122871.x

10.5694/j.1326-5377.1981.tb135961.x

Yanai J, 1984, Neurobehavioral teratology

Kline J, 1984, Perinatal epidemiology, 23

Wilson JG, 1973, Environment and birth defects

Lilienfeld AM, 1983, Practical limitations of epidemiologic methods, Environ Health Perspect, 52, 3, 10.1289/ehp.83523

10.1097/00003081-198306000-00023

Young JL, 1981, Surveillance, epidemiology and end results: incidence and mortality data, 1973–77

10.1136/bmj.292.6513.81

Romero R, 1982, Drug use in pregnancy, 41

BiggsJSG AllanJA.Medication and pregnancy.Curr Therapeutics1980; November:27–35.

Pepperell RJ, 1985, Antinauseants in pregnancy, Aust Prescriber, 8, 63

Batagol R, 1983, The 3AW reference guide on drugs and pregnancy

Briggs GG, 1983, Drugs in pregnancy and lactation

Smith DW, 1976, Recognizable patterns of human malformations

Shepard TH, 1980, Catalog of teratogenic agents

Stern JL, 1982, Drug use in pregnancy, 67

10.1056/NEJM198510033131401

10.5694/j.1326-5377.1983.tb104324.x

10.1016/S0140-6736(82)90908-4

10.1016/S0140-6736(82)90018-6

10.5694/j.1326-5377.1985.tb123132.x

Janz D, 1982, Epilepsy, pregnancy and the child

10.1016/S0140-6736(80)91387-2

10.1016/S0140-6736(83)92561-8

10.1016/S0140-6736(83)90538-X

Benke PJ, 1984, The isotretinoin teratogen syndrome, JAMA, 251, 3267, 10.1001/jama.1984.03340480049027

Shepard TH, 1983, Counselling pregnant women exposed to potentially harmful agents during pregnancy, Clin Obstet Gynecol, 26, 478, 10.1097/00003081-198306000-00029